Reuters logo
7 months ago
BRIEF-Incyte Corp , Eli Lilly amended license, development and commercialization agreement, entered into as of December 18, 2009
December 16, 2016 / 9:26 PM / 7 months ago

BRIEF-Incyte Corp , Eli Lilly amended license, development and commercialization agreement, entered into as of December 18, 2009

1 Min Read

Dec 16 (Reuters) - Incyte Corp

* Co, eli lilly amended license, development and commercialization agreement, entered into as of December 18, 2009

* Deal amended to provide $65 million milestone payment from Lilly triggered by receipt of marketing authorization for Baricitinib by European Commission Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below